Cite
Enzyme-Induced Shape-Shifting Peptide Nanocarrier Coloaded with Paclitaxel and Dipyridamole Inhibits Platelet Function and Tumor Metastasis.
MLA
Meng, Fanhu, et al. “Enzyme-Induced Shape-Shifting Peptide Nanocarrier Coloaded with Paclitaxel and Dipyridamole Inhibits Platelet Function and Tumor Metastasis.” ACS Applied Materials & Interfaces, vol. 16, no. 1, Jan. 2024, pp. 166–77. EBSCOhost, https://doi.org/10.1021/acsami.3c13855.
APA
Meng, F., Zhai, X., Ma, J., Li, A., Wang, X., & Bai, J. (2024). Enzyme-Induced Shape-Shifting Peptide Nanocarrier Coloaded with Paclitaxel and Dipyridamole Inhibits Platelet Function and Tumor Metastasis. ACS Applied Materials & Interfaces, 16(1), 166–177. https://doi.org/10.1021/acsami.3c13855
Chicago
Meng, Fanhu, Xiaoqing Zhai, Jihong Ma, Aimei Li, Xizhen Wang, and Jingkun Bai. 2024. “Enzyme-Induced Shape-Shifting Peptide Nanocarrier Coloaded with Paclitaxel and Dipyridamole Inhibits Platelet Function and Tumor Metastasis.” ACS Applied Materials & Interfaces 16 (1): 166–77. doi:10.1021/acsami.3c13855.